Not sure I understand their cash situation but looks close to going into receivership from where I stand, do they have more shares in Sangui Bio they can flog off to raise some cash, or is this part of RGS itself?
Share price looks like it wants to base, however it would be a brave punter if the cash issue is going to persist.
RGS Price at posting:
0.6¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)